Cyclooxygenases: structural, cellular, and molecular biology.

  title={Cyclooxygenases: structural, cellular, and molecular biology.},
  author={William L. Smith and David L Dewitt and R. Michael Garavito},
  journal={Annual review of biochemistry},
The prostaglandin endoperoxide H synthases-1 and 2 (PGHS-1 and PGHS-2; also cyclooxygenases-1 and 2, COX-1 and COX-2) catalyze the committed step in prostaglandin synthesis. PGHS-1 and 2 are of particular interest because they are the major targets of nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin, ibuprofen, and the new COX-2 inhibitors. Inhibition of the PGHSs with NSAIDs acutely reduces inflammation, pain, and fever, and long-term use of these drugs reduces fatal thrombotic… 

Figures and Tables from this paper

The structure of mammalian cyclooxygenases.

This review examines how the structures of COXs relate mechanistically to cyclooxygenase and peroxidase catalysis and how alternative fatty acid substrates bind within the COX active site and how differences in the structure of COx-2 result in enhanced selectivity toward COX-2 inhibitors.

Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function.

The results suggest that inhibitors of mPGES-1 may retain their antiinflammatory efficacy by depressing PGE(2), while avoiding the adverse cardiovascular consequences associated with PGHS-2-mediated PGI(2) suppression.

Selective oxygenation of N-arachidonylglycine by cyclooxygenase-2.

Cyclooxygenase-2: Biology of Prostanoid Biosynthesis and Metabolism

COX-2 is the target of NSAIDs, traditional and coxibs, thus leading to therapeutic effects and cardiovascular hazard, in some individuals, and the discovery of these novel effects of (R) enantiomers ofNSAIDs opens the way to develop novel analgesic drugs based on this mechanism of action.

The Structural Basis of Endocannabinoid Oxygenation by Cyclooxygenase-2*

The 2,3-dihydroxypropyl moiety of 1-AG binds near the opening of the cyclooxygenase channel in the space vacated by the movement of the Leu-531 side chain, validating the previous hypothesis implicating the flexibility of the Leicester side chain as a determinant for the ability of COX-2 to oxygenate endocannabinoid substrates.

Cyclooxygenase-2: a therapeutic target.

Traditional nonsteroidal anti-inflammatory drugs (NSAIDs) inhibit both enzymes, and a new class of COX-2 selective inhibitors (COXIBs) preferentially inhibit the COx-2 enzyme.

Molecular Docking studies of Novel Flavones as Cyclooxygenase- 2 (Cox 2) Inhibitors

Dock a series of flavones into the active site of COX-2 and study the binding pattern, which reports that the anti-inflammatory and the anticancer activities of the flavones may be related to each other in view of the overexpression of COx-2 in some types of cancers.

The structure of NS-398 bound to cyclooxygenase-2.

Cyclooxygenase-2 in Cardiovascular Biology

Traditional non-steroidal anti-inflammatory drugs (NSAIDs) inhibit both enzymes, and a new class of COX-2 selective inhibitors (COXIBs) preferentially inhibit the COx-2 enzyme.

Crosstalk of oncogenic and prostanoid signaling pathways

  • R. Müller
  • Biology, Medicine
    Journal of Cancer Research and Clinical Oncology
  • 2004
Work of the past decade has clearly established Cox-2 and a subset of prostanoids and their receptors as crucial players in oncogenesis that regulate, and are regulated by, pathways with essential functions inoncogenesis.



Pharmacological analysis of cyclooxygenase-1 in inflammation.

  • C. SmithY. Zhang P. Isakson
  • Medicine, Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1998
The results suggest that, in addition to the role of peripherally produced PGs, there is a critical, centrally mediated neurological component to inflammatory pain that is mediated at least in part by COX-2.

Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2*

This review compares and contrast PGHS-1 and -2 in the context of the regulation of expression of the two enzymes, the mechanisms of enzyme catalysis, and the biological significance of having two PGHSs.

Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

The structures of unliganded murine COX-2 and complexes with flurbiprofen, indomethacin and SC-558, a selective COx-2 inhibitor, determined are explained and some of the conformational changes associated with time-dependent inhibition are demonstrated.

Subcellular Localization of Prostaglandin Endoperoxide H Synthases-1 and -2 by Immunoelectron Microscopy*

It is hypothesized that PGHS-1 and -2 may reside, at least in part, in different subcellular compartments and that their compartmentation may affect their access to arachidonic acid and serve to separate the functions of the enzymes.

Cyclooxygenase-1 and -2 isoenzymes.

Comparison of Structural Stabilities of Prostaglandin H Synthase-1 and -2*

The structural stability of PG HS-2, both in the active site regions and in the subunits overall, is distinctly less than that of PGHS-1, which may contribute to the isoforms’ active site ligand selectivity.

Comparison of the Peroxidase Reaction Kinetics of Prostaglandin H Synthase-1 and -2*

Kinetic differences between the PGHS isoforms in forming or stabilizing the active cyclooxygenase species can contribute to the difference in the regulation of their cellular activities.

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

  • K. SeibertY. Zhang P. Isakson
  • Medicine, Biology
    Proceedings of the National Academy of Sciences of the United States of America
  • 1994
In an animal model of acute inflammation, a selective inhibitor of COX-2 inhibited edema at the inflammatory site and was analgesic but had no effect on PG production in the stomach and did not cause gastric toxicity.

The Membrane Binding Domains of Prostaglandin Endoperoxide H Synthases 1 and 2

Prostaglandin endoperoxide H synthases 1 and 2 (PGHS-1 and -2) are the major targets of nonsteroidal anti-inflammatory drugs. Both isozymes are integral membrane proteins but lack transmembrane